Here's Why Starbucks' CEO Is Tracking the Moderna Vaccine Rollout
Moderna has become a household name since the launch of its coronavirus vaccine in December. And it's also become a name on the radar screen of Starbucks (NASDAQ: SBUX). In fact, the coffee shop giant is paying very close attention to the rollout of Moderna's vaccine -- and those of its rivals Pfizer and Johnson & Johnson.
Starbucks is even using its Deep Brew artificial intelligence (AI) system to predict vaccination progress worldwide. Now, you might wonder why vaccine rollout would be of such interest to Starbucks. Let's look at what CEO Kevin Johnson said during the Starbucks earnings call this week.
Image source: Getty Images.
Source Fool.com
